Publications by authors named "Jian-Wei Lou"

Article Synopsis
  • Post-transplant lymphoproliferative disorders (PTLD) are serious complications following organ transplants, particularly difficult to diagnose in the central nervous system (CNS) and associated with high mortality rates.
  • The case study focuses on a patient with EBV-related CNS-PTLD and evaluates treatment effectiveness through a systematic review of 431 similar cases.
  • Findings show that rituximab combined with EBV-specific therapies has a high response rate, suggesting it could be a promising treatment option for managing PTLD after transplants.
View Article and Find Full Text PDF

Ethnopharmacological Relevance: Euphorbia kansui is a toxic Chinese herbal medicine and exhibits promising treatment to the malignant ascites (MA) in its traditional use. Ingenane-type and jastrophane-type diterpenes are demonstrated to be responsible for the toxicity and efficacy of kansui. Two representative compounds, kansuiphorin C (KPC) and kansuinin A (KA) in each type were proved to effectively reduce the ascites.

View Article and Find Full Text PDF

Malignant ascites (MA) is one of the severe complications of gastrointestinal tumors, affecting the patients' survival time and quality of life. Euphorbia kansui is a commonly used toxic Chinese herbal medicine for malignant ascites. Our previous study showed that the biological and toxicological effects of kansui were closely related to the gastrointestinal tract.

View Article and Find Full Text PDF

In this research, a new triterpenoid, tirucalla-8,24-diene-3β,11β-diol-7-one (), and eupha-8,24-diene-3β,11β-diol-7-one (), which was isolated from for the first time, together with twelve other known compounds (-), were isolated from the ethyl acetate extract of . Their structures were elucidated based on High resolution electrospray ionization mass spectrometry (HR-ESI-MS), Infrared Spectroscopy (IR), 1D and 2D Nuclear Magnetic Resonance (NMR) data. Both constituents and exhibited moderate cytotoxicity against colon cancer HCT-116, gastric cancer MKN-45 and breast cancer MCF-7.

View Article and Find Full Text PDF

The 24 h normal developing zebrafish embryos were used to evaluate the acute toxicity and the compounds of respective fractions were analyzed by UFLC-Q-TOF-MS simultaneously. Nine concentration groups with respective concentration and a blank control group were designed for each fraction to investigate their effect on survival rates of zebrafish embryos 96 h after drug administration, and calculate the median lethal concentration (LC₅₀) of different fractions to zebrafish embryos. The results showed that all of the fractions had acute toxicity to zebrafish embryos except VEKD, and the order was as follows: VEKB, VEKC, VEKA and VEKD.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Jian-Wei Lou"

  • - Jian-Wei Lou's recent research focuses on the evaluation and treatment of post-transplant lymphoproliferative disorders (PTLD) and malignant ascites, with a particular emphasis on the role of the herbal medicine Euphorbia kansui in managing these conditions.
  • - His studies include comprehensive meta-analytic approaches to PTLD, assessing the diagnostic value of Epstein-Barr virus (EBV) and exploring the effects of kansuiphorin C and kansuinin A on gut microbiota and related metabolic functions in the context of malignant ascites.
  • - Additionally, research conducted by Lou investigates the toxicity and efficacy of various fractions of E. kansui, employing advanced analytical techniques such as UPLC-MS/MS for compound quantification and toxicology assessments, highlighting their potential therapeutic application as well as the importance of safety evaluation.